The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease

The tumor necrosis factor like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 (Fn14), mediate inflammation and neuronal apoptosis in cerebral edema, ischemic stroke and multiple sclerosis. The downstream effectors and pathways linked to TWEAK-Fn14 signaling...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mustafa, Shakhawan (VerfasserIn) , Martin, H. L. (VerfasserIn) , Burkly, L. (VerfasserIn) , Costa, A. (VerfasserIn) , Martins, M. L. (VerfasserIn) , Schwaninger, Markus (VerfasserIn) , Teismann, P. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 22 January 2016
In: Neuroscience
Year: 2016, Jahrgang: 319, Pages: 116-122
ISSN:1873-7544
DOI:10.1016/j.neuroscience.2016.01.034
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.neuroscience.2016.01.034
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0306452216000622
Volltext
Verfasserangaben:S. Mustafa, H.L. Martin, L. Burkly, A. Costa, M.L. Martins, M. Schwaninger and P. Teismann

MARC

LEADER 00000caa a2200000 c 4500
001 1734534354
003 DE-627
005 20230426162605.0
007 cr uuu---uuuuu
008 201002s2016 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.neuroscience.2016.01.034  |2 doi 
035 |a (DE-627)1734534354 
035 |a (DE-599)KXP1734534354 
035 |a (OCoLC)1341368355 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Mustafa, Shakhawan  |e VerfasserIn  |0 (DE-588)1160897727  |0 (DE-627)1024291618  |0 (DE-576)506227901  |4 aut 
245 1 4 |a The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease  |c S. Mustafa, H.L. Martin, L. Burkly, A. Costa, M.L. Martins, M. Schwaninger and P. Teismann 
264 1 |c 22 January 2016 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 02.10.2020 
520 |a The tumor necrosis factor like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 (Fn14), mediate inflammation and neuronal apoptosis in cerebral edema, ischemic stroke and multiple sclerosis. The downstream effectors and pathways linked to TWEAK-Fn14 signaling are strongly implicated in the pathology of Parkinson’s disease (PD), thus indicating a putative role for TWEAK/Fn14 signaling in PD neurodegeneration. Using the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model, we aimed to determine whether genetic ablation or pharmacologic mitigation of the TWEAK protein and its Fn14 receptor affected substantia nigra and striatum Parkinsonian pathology. Changes in endogenous TWEAK protein expression were also quantified in tissue from both MPTP-treated mice and PD human samples. TWEAK protein expression was transiently increased in the striatal tissue but remained unaltered in substantia nigra tissue of MPTP-treated mice. There was also no change of TWEAK protein levels in the substantia nigra or the striatum of human PD patients as compared to matched control subjects. Mitigating the effects of endogenous TWEAK protein using neutralizing antibody did affect MPTP-mediated neurotoxicity in the substantia nigra using the sub-acute model of MPTP (30mg/kg i.p. over five consecutive days). Neither TWEAK nor Fn14 genetic ablation led to attenuation of MPTP-toxicity in the acute model. These findings suggest that TWEAK signaling might be an aspect of MPTP-mediated neuropathology and be involved in the overall neurodegenerative pathology of PD. 
650 4 |a Fn14 
650 4 |a MPTP 
650 4 |a Parkinson’s disease 
650 4 |a tumor-necrosis-factor-alpha 
650 4 |a TWEAK 
700 1 |a Martin, H. L.  |e VerfasserIn  |4 aut 
700 1 |a Burkly, L.  |e VerfasserIn  |4 aut 
700 1 |a Costa, A.  |e VerfasserIn  |4 aut 
700 1 |a Martins, M. L.  |e VerfasserIn  |4 aut 
700 1 |a Schwaninger, Markus  |e VerfasserIn  |0 (DE-588)1028374909  |0 (DE-627)730623939  |0 (DE-576)375910174  |4 aut 
700 1 |a Teismann, P.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Neuroscience  |d Amsterdam [u.a.] : Elsevier Science, 1976  |g 319(2016), Seite 116-122  |h Online-Ressource  |w (DE-627)306588625  |w (DE-600)1498423-4  |w (DE-576)081953089  |x 1873-7544  |7 nnas  |a The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease 
773 1 8 |g volume:319  |g year:2016  |g pages:116-122  |g extent:7  |a The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease 
856 4 0 |u https://doi.org/10.1016/j.neuroscience.2016.01.034  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0306452216000622  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201002 
993 |a Article 
994 |a 2016 
998 |g 1028374909  |a Schwaninger, Markus  |m 1028374909:Schwaninger, Markus  |d 50000  |e 50000PS1028374909  |k 0/50000/  |p 6 
998 |g 1160897727  |a Mustafa, Shakhawan  |m 1160897727:Mustafa, Shakhawan  |p 1  |x j 
999 |a KXP-PPN1734534354  |e 3765092665 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"recId":"1734534354","name":{"displayForm":["S. Mustafa, H.L. Martin, L. Burkly, A. Costa, M.L. Martins, M. Schwaninger and P. Teismann"]},"relHost":[{"note":["Gesehen am 20.02.20"],"id":{"issn":["1873-7544"],"eki":["306588625"],"zdb":["1498423-4"]},"recId":"306588625","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s diseaseNeuroscience","physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2016","volume":"319","extent":"7","text":"319(2016), Seite 116-122","pages":"116-122"},"language":["eng"],"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"International Brain Research Organization"}],"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1976","dateIssuedDisp":"1976-","publisher":"Elsevier Science"}],"title":[{"title_sort":"Neuroscience","title":"Neuroscience","subtitle":"an international journal under the editorial direction of IBRO"}],"pubHistory":["1.1976 -"]}],"id":{"eki":["1734534354"],"doi":["10.1016/j.neuroscience.2016.01.034"]},"note":["Gesehen am 02.10.2020"],"person":[{"family":"Mustafa","display":"Mustafa, Shakhawan","roleDisplay":"VerfasserIn","given":"Shakhawan","role":"aut"},{"display":"Martin, H. L.","family":"Martin","given":"H. L.","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Burkly","display":"Burkly, L.","role":"aut","roleDisplay":"VerfasserIn","given":"L."},{"display":"Costa, A.","family":"Costa","role":"aut","given":"A.","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","given":"M. L.","display":"Martins, M. L.","family":"Martins"},{"roleDisplay":"VerfasserIn","given":"Markus","role":"aut","display":"Schwaninger, Markus","family":"Schwaninger"},{"family":"Teismann","display":"Teismann, P.","role":"aut","roleDisplay":"VerfasserIn","given":"P."}],"title":[{"title":"The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease","title_sort":"role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease"}],"physDesc":[{"extent":"7 S."}],"origin":[{"dateIssuedDisp":"22 January 2016","dateIssuedKey":"2016"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a MUSTAFASHAROLEOFTWEA2220